Literature DB >> 17657835

Surveillance of patients following surgery with curative intent for colorectal cancer.

Steven Gan1, Katherine Wilson, Paul Hollington.   

Abstract

Surveillance after resection of colorectal cancer with curative intent is an important component of post-operative care. Clinical review, imaging, colonoscopy, and cost to the community are among significant issues to consider in planning a surveillance regime. This review aims to identify the available evidence for the use of surveillance and its individual components. The literature pertaining to follow-up of patients following potentially curative surgery for colorectal cancer was reviewed in order to formulate a summary of the wide range of clinical practice. There is evidence of improved survival of patients undergoing more intense follow-up compared with those having minimal surveillance, with an estimated overall 5-year gain of up to 10%. The efficacy of individual components of follow-up regimes remains unclear, but an overall package of 'intensive' follow-up including clinical review, liver imaging, and colonoscopy appears to be of benefit. It is cost-effective and can be specialist or community-based.

Entities:  

Mesh:

Year:  2007        PMID: 17657835      PMCID: PMC4611213          DOI: 10.3748/wjg.v13.i28.3816

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  110 in total

1.  A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer.

Authors:  R H Huebner; K C Park; J E Shepherd; J Schwimmer; J Czernin; M E Phelps; S S Gambhir
Journal:  J Nucl Med       Date:  2000-07       Impact factor: 10.057

2.  Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

Authors:  J Y Douillard; D Cunningham; A D Roth; M Navarro; R D James; P Karasek; P Jandik; T Iveson; J Carmichael; M Alakl; G Gruia; L Awad; P Rougier
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

3.  Colorectal cancer follow-up: a reassessment of empirical evidence on effectiveness.

Authors:  J Kievit
Journal:  Eur J Surg Oncol       Date:  2000-06       Impact factor: 4.424

4.  Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer.

Authors:  C Rödel; G G Grabenbauer; K E Matzel; C Schick; R Fietkau; T Papadopoulos; P Martus; W Hohenberger; R Sauer
Journal:  Dis Colon Rectum       Date:  2000-03       Impact factor: 4.585

5.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Authors:  Y Fong; J Fortner; R L Sun; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

6.  Benefits and safety of hepatic resection for colorectal metastases.

Authors:  K E Harmon; J A Ryan; T R Biehl; F T Lee
Journal:  Am J Surg       Date:  1999-05       Impact factor: 2.565

7.  Surgical experience with hepatic colorectal metastasis.

Authors:  A L Bradley; W C Chapman; J K Wright; J W Marsh; S Geevarghese; K T Blair; C W Pinson
Journal:  Am Surg       Date:  1999-06       Impact factor: 0.688

8.  Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.

Authors:  S Giacchetti; M Itzhaki; G Gruia; R Adam; R Zidani; F Kunstlinger; S Brienza; E Alafaci; F Bertheault-Cvitkovic; C Jasmin; M Reynes; H Bismuth; J L Misset; F Lévi
Journal:  Ann Oncol       Date:  1999-06       Impact factor: 32.976

9.  Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer.

Authors:  B J Kjeldsen; H Thorsen; D Whalley; O Kronborg
Journal:  Scand J Gastroenterol       Date:  1999-05       Impact factor: 2.423

10.  Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older.

Authors:  R A Popescu; A Norman; P J Ross; B Parikh; D Cunningham
Journal:  J Clin Oncol       Date:  1999-08       Impact factor: 44.544

View more
  8 in total

1.  Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.

Authors:  Khurum Khan; Avani Athauda; Katharine Aitken; David Cunningham; David Watkins; Naureen Starling; Gary J Cook; Eleftheria Kalaitzaki; Ian Chau; Sheela Rao
Journal:  Oncologist       Date:  2016-10-14

2.  Surveillance instructions and knowledge among African American colorectal cancer survivors.

Authors:  Maria Pisu; Cheryl L Holt; Aquila Brown-Galvan; Temeika Fairley; Judith Lee Smith; Arica White; Ingrid J Hall; Robert A Oster; Michelle Y Martin
Journal:  J Oncol Pract       Date:  2014-01-02       Impact factor: 3.840

Review 3.  Colorectal cancer surveillance: what's new and what's next.

Authors:  Johnie Rose; Knut Magne Augestad; Gregory S Cooper
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

4.  Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol.

Authors:  Salvador Pita Fernández; Sonia Pértega Díaz; Beatriz López Calviño; Paloma González Santamaría; Teresa Seoane Pillado; Francisco Arnal Monreal; Francesc Maciá; María Antonia Sánchez Calavera; Alejandro Espí Macías; Manuel Valladares Ayerbes; Alejandro Pazos; Margarita Reboredo López; Luis González Saez; María Ramos Montserrat; Josep María Segura Noguera; Isabel Monreal Aliaga; Luis González Luján; María Martín Rabadán; Cristiane Murta Nascimento; Olga Pueyo; Marta Maia Boscá Watts; Elena Cabeza Irigoyen; Montserrat Casmitjana Abella; Marina Pinilla; Ana Costa Alcaraz; Amador Ruiz Torrejón; Andrea Burón Pust; Concepción García Aranda; María de Lluc Bennasar; Sergio Lafita Mainz; Maite Novella; Hermini Manzano; Catalina Vadell; Esther Falcó; Magdalena Esteva
Journal:  BMC Cancer       Date:  2010-10-05       Impact factor: 4.430

5.  Intensive surveillance following curative treatment of colorectal cancer allows effective treatment of recurrence even if limited to 4 years.

Authors:  Katie Adams; Lynne Higgins; Stella Beazley; Savvas Papagrigoriadis
Journal:  Int J Colorectal Dis       Date:  2015-08-30       Impact factor: 2.571

6.  A 66-Year-Old Man Presenting with Port-Site Metastatic Gastric Adenocarcinoma 4 Years After Laparoscopic Resection of a Rectal Adenocarcinoma.

Authors:  Riyadh Hakami; Elham Alzahrani; Ahmed Binjaloud; Sulaiman Alshammari; Turki Alshammari; Amany A Fathaddin; Mohammed Ayesh Zayed; Maha-Hamadien Abdulla; Omar Al-Obeed
Journal:  Am J Case Rep       Date:  2022-05-04

7.  Risk Factors Predicting Colorectal Cancer Recurrence Following Initial Treatment: A 5-year Cohort Study

Authors:  Mohammad Zare-Bandamiri; Mohammad Fararouei; Shadi Zohourinia; Nima Daneshi; Mostafa Dianatinasab
Journal:  Asian Pac J Cancer Prev       Date:  2017-09-27

8.  Spatial domain analysis predicts risk of colorectal cancer recurrence and infers associated tumor microenvironment networks.

Authors:  Shikhar Uttam; Andrew M Stern; Christopher J Sevinsky; Samantha Furman; Filippo Pullara; Daniel Spagnolo; Luong Nguyen; Albert Gough; Fiona Ginty; D Lansing Taylor; S Chakra Chennubhotla
Journal:  Nat Commun       Date:  2020-07-14       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.